Advertisement

Organisation › Details
Fresenius (Group)
Fresenius Medical Care is the world’s largest provider of products and services for individuals with renal diseases of which around 3.4 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,003 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 342,488 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the company provides related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS). *
![]() |
Industry | pharmaceutical |
Industry 2 | medical device | |
![]() |
Person | Sturm, Stephan (Fresenius 202205 Supervisory Board Chair of Fresenius Medical Care Management + CEO of Fresenius) |
Person 2 | Schneider, Ulf Mark (Fresenius 201207 CEO) | |
![]() |
Region | Bad Homburg |
Country | Germany | |
Street | 1 Else-Kröner-Str. | |
City | 61532 Bad Homburg v.d.H. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | J: more than 100,0 (2015-12-31) |
Currency | EUR | |
Annual sales | 27,626,000,000 (sales, consolidated (2015) 2015-12-31) | |
Profit | 2,297,000,000 (2015-12-31) | |
Cash | 1,044,000,000 (2015-12-31) | |
* Document for »About Section«: eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Fresenius (Group)
- [1] Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg....
- [2] Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board"....
- [3] Thermosome GmbH. (5/24/23). "Press Release: Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001". Munich....
- [4] Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care"....
- [5] Fresenius Medical Care AG & Co. KGaA. (5/3/22). "Press Release: Dr. Carla Kriwet to Succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care"....
- [6] Fresenius Medical Care AG & Co. KGaA. (8/30/21). "Press Release: Fresenius Medical Care Increases Investment in Humacyte, Accompanies Human Acellular Vessel Developer’s Stock Market Launch"....
- [7] Humacyte, Inc.. (2/17/21). "Press Release: Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisitio...
- [8] Rentschler Biopharma SE. (6/17/20). "Press Release: Rentschler Biopharma SE Appoints Alexander Dettmer as Chief Financial Officer". Laupheim & Milford, MA....
- [9] Bio-Techne Corporation. (1/21/20). "Press Release: Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies". Miami, FL....
- [10] eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top